Navigation Links
Aflac Agents and Employees Boost Bone Marrow Registry

COLUMBUS, Ga., Dec. 15 /PRNewswire/ -- Hundreds of Aflac agents and employees will be queuing up in the next few days to have their cheeks swabbed as part of a new company initiative to boost the rolls of the National Marrow Donor Program. Aflac's Bone Marrow program kicks off at the company's annual national sales conference on December 12 in Atlanta.

The bone marrow registration effort was inspired by Steve Karas, an Aflac regional sales coordinator in Boston, whose stem cell donation recently helped save the life of Matthew Welling, a young Aflac claimant in New York. Matthew's parents had been told that without a transplant, he stood little chance of living beyond childhood. Matthew's doctors searched the National Bone Marrow registry for a donor and found Steve Karas.

"Through Steve's story we learned more about the pressing need for bone marrow registrants and wanted to do something as an organization to help," said Paul Amos, president and chief operating officer of the Georgia-based insurance company.

Indeed, the need is great. Individuals with life-threatening diseases such as leukemia and lymphoma must find a donor whose tissue type matches their own. Ideal candidates for a match are usually from the same ethnic background and race. The National Marrow Donor Program has about 11 million registrants today, but 61 percent of patients who need a bone marrow transplant do not receive one. And that's just among Caucasians. Among other racial groups, the match rate is far lower. For instance, about 83 percent of African Americans in need of a transplant do not receive one because African Americans are severely underrepresented on the donor registry. Individuals from racially or ethnically diverse heritage represent only 26 percent of the entire donor registry.

"On a daily basis, about 6,000 people search the registry looking for a life-saving match," said Dr. William G. Woods, director of the Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta. "Increasing the pool of registrants increases the likelihood of a match, and will save lives."

About Aflac:

For more than 50 years, Aflac products have given policyholders the opportunity to direct cash where it is needed most when a life-interrupting medical event causes financial challenges. Aflac is the number one provider of guaranteed-renewable insurance in the United States and the number one insurance company in terms of individual insurance policies in force in Japan. Our insurance products provide protection to more than 40 million people worldwide. Aflac has been included in Fortune magazine's listing of America's Most Admired Companies for seven years and in Fortune magazine's list of the 100 Best Companies to Work For in America for ten consecutive years. Aflac has also been recognized three times by both Fortune magazine's listing of the Top 50 Employers for Minorities and Working Mother magazine's listing of the 100 Best Companies for Working Mothers. Aflac Incorporated is a Fortune 500 company listed on the New York Stock Exchange under the symbol AFL. To find out more about Aflac, visit .

About the National Marrow Donor Program:

The NMDP facilitates unrelated marrow and cord blood transplants as a single point of access for a long-standing collaborative network of national and international leading medical facilities in marrow and cord blood transplantation. The NMDP connects patients, doctors, donors and researchers to the resources they need to help more people live longer and healthier lives. For more information call 1 (800) MARROW-2 or visit . Join online at .

    (Photo: )
    (Logo: )

    Media Contacts:              Analyst and Investment Contact:
    Laura Kane                   Kenneth S. Janke Jr.
    Aflac Incorporated           Aflac Incorporated
    706.596.3493                 1.800.235.2667, Option 3; Fax: 706.324.6330    

    Jon A. Sullivan
    Aflac Incorporated

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Aflac Announces Resignation of U.S. Marketing Officer
2. Aflac Incorporated to Release Third Quarter Results On October 23, 2007
3. Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend
4. Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas
5. Aflac Japan To Offer Cancer Insurance Product Through Japan Post
6. Aflac Incorporated to Present at the Goldman Sachs Financial Services CEO Conference 2007
7. Aflac to Sponsor Iron Girl
8. Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%
9. Aflac Incorporated Announces Fourth Quarter Results
10. Training Magazine Applauds Aflacs Employee Learning Programs
11. Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... ... 1980s we have seen vast improvements in scientific research and discoveries, leading us ... providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition ...
(Date:12/1/2015)... ... December 01, 2015 , ... The ... been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s first portable ... Meeting from November 29 to December 4, 2015. , MED-TAB is expected ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... San Francisco, CA (PRWEB) , ... December 01, ... ... The Behavioral Health Center of Excellence (BHCOE) today announced that the organization has ... based in San Francisco, with a Distinguished Award. The award celebrates exceptional special ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, ... in the United States. Clarity is a Superior Dual Wavelength Platform which combines ... single platform that is easy to own and operate. , For over a ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... -- CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical ... that it has reached its enrollment target of 400 ... trial of aldoxorubicin in patients with previously treated soft ... in Q1 2016. The Phase 3 trial is a randomized, ... from the FDA at 79 sites in ...
(Date:12/1/2015)... Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), a ... of therapies for cardiovascular conditions via the inhalation route, ... in Australia . InCarda is planning ... Australia in the first half of ... medical centers in Adelaide and ...
(Date:12/1/2015)... , Dec. 1, 2015  Booth #3506 – Claymount is ... the annual meeting of the Radiological Society of ... this year. Based in the Netherlands ... Varian Medical Systems (NYSE: VAR ) and is one ... chambers and solid state automatic exposure control systems for controlling ...
Breaking Medicine Technology: